- Home
- TRMK vs DYN Comparison
TRMK vs DYN Comparison
Compare TRMK & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMK
- DYN
- Stock Information
- Founded
- TRMK 1889
- DYN 1984
- Country
- TRMK United States
- DYN United States
- Employees
- TRMK N/A
- DYN N/A
- Industry
- TRMK Major Banks
- DYN Medicinal Chemicals and Botanical Products
- Sector
- TRMK Finance
- DYN Health Care
- Exchange
- TRMK Nasdaq
- DYN Nasdaq
- Market Cap
- TRMK 2.3B
- DYN 2.6B
- IPO Year
- TRMK 1987
- DYN 2020
- Fundamental
- Price
- TRMK $36.50
- DYN $14.01
- Analyst Decision
- TRMK Buy
- DYN Strong Buy
- Analyst Count
- TRMK 6
- DYN 10
- Target Price
- TRMK $38.17
- DYN $50.78
- AVG Volume (30 Days)
- TRMK 280.4K
- DYN 2.2M
- Earning Date
- TRMK 01-28-2025
- DYN 03-04-2025
- Dividend Yield
- TRMK 2.63%
- DYN N/A
- EPS Growth
- TRMK 35.05
- DYN N/A
- EPS
- TRMK 3.65
- DYN N/A
- Revenue
- TRMK $519,746,999.00
- DYN N/A
- Revenue This Year
- TRMK N/A
- DYN N/A
- Revenue Next Year
- TRMK $3.88
- DYN N/A
- P/E Ratio
- TRMK $49.38
- DYN N/A
- Revenue Growth
- TRMK N/A
- DYN N/A
- 52 Week Low
- TRMK $25.24
- DYN $13.07
- 52 Week High
- TRMK $40.73
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- TRMK 45.15
- DYN 37.85
- Support Level
- TRMK $37.51
- DYN $13.59
- Resistance Level
- TRMK $38.36
- DYN $14.50
- Average True Range (ATR)
- TRMK 1.00
- DYN 0.98
- MACD
- TRMK -0.15
- DYN 0.32
- Stochastic Oscillator
- TRMK 2.02
- DYN 22.90
About TRMK Trustmark Corporation
Trustmark Corp is a s a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee and Texas. Its principal products and services include, Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services and others. The company is managed along three operating segments; General Banking, Wealth Management and Insurance. The General Banking segment which generates the majority of the revenue provides all traditional banking products and services, including loans, deposits and also consists of internal operations.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.